Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print January 9, 2008
DOI: 10.2337/db07-1256

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-1256v1
57/4/909    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodie, G. M.
Right arrow Articles by Green, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodie, G. M.
Right arrow Articles by Green, E. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

B Cells Promote Intra-Islet CD8+ Cytotoxic T Lymphocyte Survival To Enhance Type 1 Diabetes

Gillian M. Brodie, BSc1, Maja Wallberg, PhD1, Pere Santamaria, MD, PhD2, F. Susan Wong, MBBS, PhD3, and E. Allison Green, PhD1

1Department of Pathology, Cambridge Institute for Medical Research, Cambridge University, Addenbrooke's Hospital, Hills Road, Cambridge. CB2 0XY. UK
2Julia McFarlane Diabetes Research Centre and Department of Microbiology and Infectious Diseases, Faculty of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada
3Department of Cellular and Molecular Medicine, School of Medical Sciences, University of Bristol BS8 1TD, UK

Objective: To determine the role of B cells in promoting CD8+ T cell-mediated β cell destruction in chronically inflamed islets.

Research Design and Methods: RIP-TNF{alpha}-NOD mice were crossed to B cell deficient NOD mice and diabetes development monitored. In vitro antigen presentation assays, in vivo administration of the bromodeoxyuridine coupled to flow cytometry assays assessed intra-islet T cell activation in the absence or presence of B cells. CD4+Foxp3+ activity in the absence or presence of B cells was tested using in vivo depletion techniques. Cytokine production and apoptosis assays determined the capacity of CD8+ T cells transform to CTL and survive within inflamed islets in the absence or presence of B cells.

Results: B cell deficiency significantly delayed diabetes development in chronically inflamed islets. Re-introduction of B cells incapable of secreting Ig restored diabetes development. Both CD4+ and CD8+ T cell activation was unimpaired by B cell deficiency and delayed disease was not due to CD4+Foxp3+ T cell suppression of T cell responses. Instead at the CTL transition stage, B cell deficiency resulted in apoptosis of intra-islet CTL.

Conclusion: In inflamed islets, B cells are central for the efficient intra-islet survival of CTL thereby promoting type 1 diabetes development.


Correspondence: allison.green{at}cimr.cam.ac.uk


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.